Edwards Lifesciences Corp. (EW) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $91.60 -1.04%
Financial Fact:
Research and development expenses: 113.1M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development expenses: 113.1M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Edwards Lifesciences Corp. (NYSE: EW) reported Q3 EPS of $0.38, $0.01 worse than the analyst estimate of $0.39. Revenue for the quarter came in at $412.7 million versus the consensus estimate of $405.09 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
